Journals / Klimik Dergisi / 2011 / Cilt: 24 - Sayı: 1

The evaluation of procalcitonin as a diagnostic and prognostic marker of bacterial infections in febrile neutropenic patients

Febril nötropenik hastalarda bakteriyel infeksiyonların tanısal ve prognostik bir göstergesi olarak prokalsitoninin değerlendirilmesi

Pages
24–30
Publication Date
2022-10-18
DOI
—
🏛️Bibliographic metadata and full text access for this article are provided via DergiPark.
DergiPark Record ↗
✨

AI Summary & Key Takeaways

AI Insight
⚡ TL;DR(Too Long; Didn't Read)

Procalcitonin levels differed significantly between patients with and without severe sepsis (p

📌 3 Key Takeaways

🎯
Objective & Hypothesis:Objective: The aim of this study was to evaluate the role of procalcitonin (PCT) in the diagnosis, prognosis and follow-up of bacterial infections in febrile neutropenic patients in comparison to the standard parameter, C-reactive protein (CRP).
📊
Key Findings & Data:Methods: 40 febrile neutropenic episodes of 37 patients with cancer undergoing chemotherapy were classified as fever of unknown origin (FUO), microbiologically or clinically documented infection.
💡
Conclusion & Impact:Procalcitonin levels differed significantly between patients with and without severe sepsis (p
🔬Design:Research Article
📍Scope:Comprehensive Sample
⚙️Variables:Domain Parameters

Abstract

Objective: The aim of this study was to evaluate the role of procalcitonin (PCT) in the diagnosis, prognosis and follow-up of bacterial infections in febrile neutropenic patients in comparison to the standard parameter, C-reactive protein (CRP). Methods: 40 febrile neutropenic episodes of 37 patients with cancer undergoing chemotherapy were classified as fever of unknown origin (FUO), microbiologically or clinically documented infection. Four sequential serum samples were obtained at the onset of neutropenia, on the first and third days of fever and on the day of defervescence, or on day 5 or 7 of an unresolved fever. Results: At the onset of neutropenia, the PCT levels were found to be normal whereas CRP levels were found to be elevated in all patients. With the febrile episode, PCT levels were elevated in all types of infections which were significantly higher for documented infections compared to FUO (p< 0.05). Procalcitonin levels differed significantly between patients with and without severe sepsis (p

Özet

Amaç: Maligniteli hastalardaki febril nötropeni ataklarında prokalsitonin (PCT)in bakteriyel infeksiyonların tanısal ve prognostik bir göstergesi olarak standard bir parametre olan C-reaktif protein (CRP) ile karşılaştırılıp değerlendirilmesi amaçlandı. Yöntemler: Kemoterapiye bağlı 37 hastadaki 40 febril nötropenik atak üç gruba ayrıldı: nedeni bilinmeyen ateş (NBA), mikrobiyolojik olarak tanımlanmış infeksiyon ve klinik olarak tanımlanmış infeksiyon. Nötropeni başlangıcında, ateşin ilk ve üçüncü günü, ateşin düştüğü gün ya da tedaviye yanıtsız hastalarda tedavinin 5-7. günü olmak üzere toplam dört kan örneği alındı. Bulgular: Tüm ataklarda nötropeni başlangıcında PCT düzeyleri normal değerlerde bulunurken, CRP düzeyleri normal değerlerin üzerinde saptandı. Ateşin üçüncü günü PCTdeki yüksekliğin tanımlanmış infeksiyonu olan gruplarda, NBA grubuna göre daha fazla olduğu gözlendi (p

🔖

Cite This Article

ŞENOL, E., HAZNEDAR, R., YALÇIN, S., YETKİN, F. (2022). The evaluation of procalcitonin as a diagnostic and prognostic marker of bacterial infections in febrile neutropenic patients. Klimik Dergisi, Cilt: 24 - Sayı: 1, 24–30. https://ajindex.com/articles/573668

📄 Full Text PDF Viewer

📄

PDF görüntüleyici hazırlanıyor...

References (12)

  1. Bille J. Laboratory diagnosis of infections in febrile neutropenic or immunocompromised patients. Int J Antimicrob Agents. 2000
  2. 16(2): 87-9. [Crossref] Yetkin Fet al. Febril Nötropenideki Bakteriyel İnfeksiyonlarda Prokalsitonin 29 2.Giamarellou H, Antoniadou A. Infectious complications of febrile leukopenia. Infect Dis Clin North Am. 2001
  3. 15(2): 457-82. [Crossref] 3.Mulinde J, Joshi M. The diagnostic and therapeutic approach to lower respiratory tract infections in the neutropenic patient. J Antimicrob Chemother. 1998
  4. 41(Suppl. D): 51-5. [Crossref] 4.Kern WV. Risk assessment and treatment of low-risk patients with febrile neutropenia. Clin Infect Dis. 2006
  5. 42(4): 533-40. [Crossref] 5.Engel A, Steinbach G, Kern P, Kern WV. Diagnostic value of procalcitonin serum levels in neutropenic patients with fever: comparison with interleukin-8. Scand J Infect Dis. 1999
  6. 31(2): 185-9. 6.Fleischhack G, Cipic D, Juettner J, Hasan C, Bode U. Procalcitonin-a sensitive inflammation marker of febrile episodes in neutropenic children with cancer. Intensive Care Med. 2000
  7. 26(Suppl. 2): S202-11. [Crossref] 7.Fleischhack G, Kambeck I, Cipic D, Hasan C and Bode U. Procalcitonin in paediatric cancer patients: its diagnostic relevance is superior to that of C-reactive protein, interleukin 6, interleukin 8, soluble interleukin 2 receptor and soluble tumour necrosis factor receptor II. Br J Haematol. 2000
  8. 111(4): 1093-102. [Crossref] 8.Giamarellos-Bourboulis EJ, Grecka P, Poulakou G, Anargyrou K, Katsilambros N, Giamarellou H. Assessment of procalcitonin as a diagnostic marker of underlying infection in patients with febrile neutropenia. Clin Infect Dis. 2001
  9. 32(12): 1718-25. [Crossref] 9.Hambach L, Eder M, Dammann E, et al. Diagnostic value of procalcitonin serum levels in comparison with C-reactive protein in allogeneic stem cell transplantation. Haematologica. 2002
  10. 87(6):643-51. [Crossref] 10.Gendrel D, Bohuon C. Procalcitonin as a marker of bacterial infection. Pediatr Infect Dis J. 2000
  11. 19(8): 679-87. [Crossref] 11.Meisner M. Procalcitonin (PCT). A New, Innovative Infection Parameter. Biochemical and Clinical Aspects. 3rd ed. Stuttgart: Thieme, 2000. 12.Russwurm S, Wiederhold M, Oberhoffer M, Stonans I, Zipfel PF, Reinhart K. Molecular aspects and natural source of procalcitonin. Clin Chem Lab Med. 1999
  12. 37(8): 789-97. [Crossref] 13.Ruokonen E, Nousiainen T, Pulkki K, Takala J. Procalcitonin concentrations in patients with neutropenic fever. Eur J Clin Microbiol In